CVR number 33366949
Industry 86.9090 Other human health activities

ANJA NIELSEN ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.6% 13.9% 20.0% 10.4% 5.0%  
Credit score (0-100)  17 16 5 23 43  
Credit rating  BB BB B BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  24 16 29 32 20  
Gross profit  12.5 -7.3 19.2 -1.3 1.4  
EBITDA  12.5 -7.3 19.2 -1.3 1.4  
EBIT  12.5 -7.3 19.2 -1.3 1.4  
Pre-tax profit (PTP)  12.3 -6.9 19.0 -1.7 493.4  
Net earnings  9.5 -5.4 14.9 -1.4 493.2  
Pre-tax profit without non-rec. items  12.3 -6.9 19.0 -1.7 493  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  11.0 5.6 20.5 19.1 512  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  21.4 12.6 36.2 29.1 520  
Net Debt  -2.4 -5.1 -36.2 -28.8 -20.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  24 16 29 32 20  
Net sales growth  -16.0% -33.6% 80.2% 11.3% -37.0%  
Gross profit  12.5 -7.3 19.2 -1.3 1.4  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  21 13 36 29 520  
Balance sheet change%  40.9% -41.2% 187.4% -19.7% 1,688.1%  
Added value  12.5 -7.3 19.2 -1.3 1.4  
Added value %  52.0% -45.7% 66.8% -3.9% 6.8%  
Investments  0 0 0 0 0  
Net sales trend  -1.0 -2.0 1.0 2.0 -1.0  
EBIT trend  1.0 -1.0 1.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  52.0% -45.7% 66.8% -3.9% 6.8%  
EBIT %  52.0% -45.7% 66.8% -3.9% 6.8%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  39.7% -33.9% 51.7% -4.4% 2,444.4%  
Profit before depreciation and extraordinary items %  39.7% -33.9% 51.7% -4.4% 2,444.4%  
Pre tax profit less extraordinaries %  51.1% -43.4% 66.2% -5.2% 2,445.7%  
ROA %  67.0% -40.7% 79.2% -3.8% 179.8%  
ROI %  199.0% -84.0% 148.4% -6.4% 185.8%  
ROE %  152.8% -65.1% 114.0% -7.2% 185.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  51.0% 44.4% 56.5% 65.5% 98.6%  
Relative indebtedness %  44.0% 43.9% 54.8% 31.3% 37.3%  
Relative net indebtedness %  34.0% 11.8% -71.2% -58.7% -62.0%  
Net int. bear. debt to EBITDA, %  -19.2% 70.1% -188.4% 2,295.1% -1,456.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.1 1.8 2.3 2.9 3.7  
Current Ratio  2.1 1.8 2.3 2.9 3.7  
Cash and cash equivalent  2.4 5.1 36.2 28.8 20.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  240.7 0.0 0.0 0.0 101.8  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  89.2% 79.0% 126.0% 90.0% 137.0%  
Net working capital  11.0 5.6 20.5 18.8 20.1  
Net working capital %  45.8% 35.1% 71.2% 58.7% 99.7%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0